An interventional study of ciSNaP in Post Surgical Wound, sponsored by KCI USA, Inc. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-25.
Sponsored by KCI USA, Inc · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the safety and efficacy of the Closed-Incision SNaP Device.
519 studies on the registry are indexed under Surgical Wound; 71 are open to participants now.
This study's enrollment of 59 is below the median of 80 across 412 interventional studies indexed under Surgical Wound.
Browse Surgical Wound studies →KCI USA, Inc is the lead sponsor of 17 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: ciSNaP
SNaP disposable, mechanically powered Negative Pressure Wound Therapy System
Frequency of Complaints About Device Use and Operation
Frequency of complaints about device use and operation
Time frame: 30 days
| Milestone | ciSNaP |
|---|---|
| Started | 59 |
| Completed | 51 |
| Not completed | 8 |
| Withdrew: Other | 8 |
Frequency of complaints about device use and operation
No measurements were reported for this outcome.
Collected over 30 Days. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| ciSNaP | 0/51 (0%) | 0/51 (0%) | 6/51 (11.8%) |
| Event | ciSNaP |
|---|---|
| Stitch granulomaSkin and subcutaneous tissue disorders | 3/51 |
| Minor dehiscenceSkin and subcutaneous tissue disorders | 3/51 |
| BlisterSkin and subcutaneous tissue disorders | 2/51 |
| Mild surgical infectionInfections and infestations | 2/51 |
| Congestive Heart Failure exacerbationCardiac disorders | 1/51 |
| HemarthrosisBlood and lymphatic system disorders | 1/51 |
| LymphoceleBlood and lymphatic system disorders | 1/51 |
| Age, Continuous(years) | ciSNaP |
|---|---|
| Mean | 68 ± 11.8 |
| Sex: Female, Male(Participants) | ciSNaP |
|---|---|
| Female | 18 |
| Male | 33 |
| Race/Ethnicity, Customized(Participants) | ciSNaP |
|---|---|
| Ethnicity (White) | 41 |
| Ethnicity (Non-White) | 10 |
| Region of Enrollment(Participants) | ciSNaP |
|---|---|
| United States | 51 |
This study is terminated, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
KCI USA, Inc